{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:39:31Z","timestamp":1789087171516,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rpth.2025.103210","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:39:21Z","timestamp":1759797561000},"page":"103210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Haemostasis alterations in immune thrombocytopenia and their clinical significance"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-333X","authenticated-orcid":false,"given":"Thomas","family":"Pincez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bonnefoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103210_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","article-title":"Bleeding complications in immune thrombocytopenia","volume":"2015","author":"Arnold","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.rpth.2025.103210_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.13787","article-title":"Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study","volume":"174","author":"N\u00f8rgaard","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ejh.12777","article-title":"Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis","volume":"97","author":"Doobaree","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103820","article-title":"Recent advances in the mechanisms and treatment of immune thrombocytopenia","volume":"76","author":"Provan","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.rpth.2025.103210_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000574","article-title":"Immune thrombocytopenia: recent advances in pathogenesis and treatments","volume":"5","author":"Audia","year":"2021","journal-title":"HemaSphere"},{"key":"10.1016\/j.rpth.2025.103210_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.19079","article-title":"The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia","volume":"203","author":"Yazdanbakhsh","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ijlh.14216","article-title":"Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts","volume":"46","author":"Altahan","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.103210_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.16439","article-title":"Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet-associated anti-\u03b1IIb\u03b23 antibodies and thrombopoietin receptor agonists","volume":"189","author":"Nishiura","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood-2013-08-519686","article-title":"Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts","volume":"123","author":"van Bladel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103210_bib11","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00277-023-05466-1","article-title":"Bleeding risk assessment in immune thrombocytopenia","volume":"102","author":"Mishra","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.103210_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2362.2007.01855.x","article-title":"Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia","volume":"37","author":"Panzer","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rpth.2025.103210_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0609.2007.00900.x","article-title":"Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia","volume":"79","author":"Panzer","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib14","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1182\/blood-2011-11-393900","article-title":"In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation","volume":"119","author":"Psaila","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103210_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00277-011-1249-5","article-title":"Platelet activation and function during eltrombopag treatment in immune thrombocytopenia","volume":"91","author":"Haselboeck","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.103210_bib16","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1038\/s41598-021-88900-6","article-title":"Platelet function and bleeding at different phases of childhood immune thrombocytopenia","volume":"11","author":"Ignatova","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2025.103210_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2141.1998.00568.x","article-title":"Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit","volume":"100","author":"Cahill","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/pbc.21000","article-title":"Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia","volume":"47","author":"Panzer","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpth.2025.103210_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12185-017-2207-3","article-title":"Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura","volume":"105","author":"Suntsova","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rpth.2025.103210_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.thromres.2013.09.009","article-title":"Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders","volume":"132","author":"Connor","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103210_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2023.01.012","article-title":"Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia","volume":"223","author":"Mehic","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103210_bib22","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3390\/ijms21093035","article-title":"Heterogeneity of integrin \u03b1IIb\u03b23 function in pediatric immune thrombocytopenia revealed by continuous flow cytometry analysis","volume":"21","author":"Martyanov","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2025.103210_bib23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjh.14412","article-title":"Procoagulant profile in patients with immune thrombocytopenia","volume":"175","author":"\u00c1lvarez-Rom\u00e1n","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH13-10-0873","article-title":"Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia","volume":"112","author":"Alvarez Rom\u00e1n","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/08880011003663390","article-title":"Platelet microparticles in immune thrombocytopenic purpura in pediatrics","volume":"27","author":"Tantawy","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.rpth.2025.103210_bib26","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.thromres.2012.11.021","article-title":"Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura","volume":"131","author":"Sewify","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103210_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH13-10-0873","article-title":"Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia","volume":"112","author":"Alvarez Rom\u00e1n","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0049-3848(02)00260-8","article-title":"Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function","volume":"107","author":"Olsson","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103210_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3324\/haematol.2019.236117","article-title":"Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan","volume":"106","author":"Marini","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103210_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/09537104.2019.1696456","article-title":"Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?","volume":"31","author":"Lozano","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.103210_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2019.11.031","article-title":"Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists","volume":"185","author":"Garabet","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103210_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103210_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12964-018-0235-0","article-title":"Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones","volume":"16","author":"Elaskalani","year":"2018","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.rpth.2025.103210_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-0039-1678706","article-title":"Platelet apoptosis and PAI-1 are involved in the pro-coagulant state of immune thrombocytopaenia patients treated with thrombopoietin receptor agonists","volume":"119","author":"Justo Sanz","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib35","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3324\/haematol.2021.279751","article-title":"Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia","volume":"107","author":"Zheng","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103210_bib36","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.jtha.2024.07.034","article-title":"Fibrinolysis is impaired in patients with primary immune thrombocytopenia","volume":"22","author":"Schramm","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12288-024-01873-0","article-title":"Plasminogen activator inhibitor 1 in patients with primary immune thrombocytopenia: a case control study","volume":"41","author":"Sheeba","year":"2024","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.rpth.2025.103210_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/09537104.2017.1394451","article-title":"Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia","volume":"30","author":"Garabet","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.103210_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/09537104.2013.869312","article-title":"Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura","volume":"26","author":"Kim","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.103210_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211054514","article-title":"Endothelial activation and immune thrombocytopenia: an engagement waiting for consolidation","volume":"27","author":"Efat","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103210_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.12358","article-title":"Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome","volume":"93","author":"Dunoyer-Geindre","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.103210_bib42","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/j.rpth.2025.103210_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26812","article-title":"Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk","volume":"65","author":"McDonnell","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpth.2025.103210_bib44","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/bjh.16164","article-title":"Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment","volume":"187","author":"Ignatova","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood-2015-02-628461","article-title":"Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP","volume":"126","author":"Frelinger","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103210_bib46","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/j.1538-7836.2011.04506.x","article-title":"Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia","volume":"9","author":"Psaila","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib47","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00043426-200212000-00012","article-title":"Soluble P-Selectin, Interleukin 6, and thrombopoietin levels in children with acute and chronic idiopathic thrombocytopenic purpura and their relationship with mega-dose methylprednisolone therapy: a pilot study","volume":"24","author":"Olcay","year":"2002","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"10.1016\/j.rpth.2025.103210_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10238-022-00790-8","article-title":"Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopenia","volume":"22","author":"Ou","year":"2022","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.rpth.2025.103210_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002770050435","article-title":"Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura","volume":"77","author":"Haznedaro\u011flu","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.103210_bib50","first-page":"334","article-title":"Clinical significance of platelet microparticles in autoimmune thrombocytopenias","volume":"119","author":"Jy","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.rpth.2025.103210_bib51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjh.12929","article-title":"Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia","volume":"166","author":"Greene","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103210_bib52","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jtha.2025.01.011","article-title":"Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause","volume":"23","author":"Mehic","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103210_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/anae.16463","article-title":"Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta-analysis","volume":"80","author":"Dias","year":"2025","journal-title":"Anaesthesia"},{"key":"10.1016\/j.rpth.2025.103210_bib54","article-title":"Predicting bleeding risk in a Chinese immune thrombocytopenia (ITP) population: development and assessment of a new predictive nomogram","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:43:40Z","timestamp":1767062620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925005345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2475037925005345"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103210","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haemostasis alterations in immune thrombocytopenia and their clinical significance","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103210"}}